News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

uniQure Announces Closing of Initial Public Offering



2/10/2014 9:22:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AMSTERDAM, The Netherlands, Feb. 10, 2014 (GLOBE NEWSWIRE) -- uniQure B.V. ("uniQure"), a leader in human gene therapy, today announced the closing of its previously announced initial public offering of 5,400,000 ordinary shares at an initial public offering price of $17.00 per ordinary share. In addition, uniQure granted the underwriters a 30-day option from February 5, 2014 to purchase up to an additional 810,000 ordinary shares from uniQure at the public offering price, less underwriting discounts. uniQure's ordinary shares were approved for listing on the NASDAQ Global Select Market and began trading under the symbol "QURE" on February 5, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
uniQure
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES